AMPK -- the enzyme that makes physical activity healthy

January 02, 2017

ampk Physical activity benefits diabetics and others with insulin resistance. One of the reasons is that a single bout of physical activity increases the effectiveness of insulin. Thus, physical activity helps to reduce the risk of developing diabetes, while also reducing the effects of diabetes if it does set in. Until now, no one has understood the underlying mechanism of this phenomenon.

New research from the University of Copenhagen's Department of Nutrition, Exercise and Sports reports that the enzyme AMP-activated protein kinase (AMPK) plays a crucial role in enhancing the ability of insulin to stimulate glucose uptake in muscles. The discovery may be a breakthrough in finding a medical pathway to improve the health of people with limitations for physical activity.

"AMPK is central for insulin sensitivity in muscles, and thereby for the ability of muscles to take up glucose immediately after physical activity. That our research group has been able to demonstrate such an important and basic physiological role of AMPK in muscles is fantastic, and a reward after many years of effort," according to Professor Jørgen Wojtaszewski, who had overall responsibility for the group's work.

Wojtaszewski continues: "This is excellent news for people with decreased insulin sensitivity. We can now work from the standpoint that activating AMPK, both medicinally as well as through physical activity, will enhance the effectiveness of insulin in the muscles of these people."

Moving towards an 'exercise pill'

The study's main experiments were conducted on laboratory animals in which the genes coding for AMPK specifically were removed in skeletal muscle. The ability of these mice to increase muscle insulin sensitivity after a single exercise bout was fully ablated. Over the last years the research group has conducted several experiments that show that it is highly probable that AMPK plays a similar role in muscles of man. In addition, last year, the group demonstrated that medicinal activation of AMPK could increase insulin sensitivity in muscles of mice.

"While physical activity is clearly preferred, because it improves health and welfare in a great many areas and ways, our finding points to a medicinal way to improve health that can benefit those who are limited in their ability to be physically active. This could include people with physical handicaps, ill people forced to stay in bed for more than a few days or of course those who do not fancy physical activity at all. Popularly put, we are moving towards the development of an 'exercise pill'", says Postdoc Rasmus Kjøbsted, lead author of the article that catalogued the group's research.

He concludes: "Moreover, our findings suggest that some types of physical activity are likely more effective than others in increasing insulin sensitivity. But more experiments are required to further clarify this."
-end-
The study is published as the article, Enhanced Muscle Insulin Sensitivity After Contraction/Exercise is Mediated by AMPK, in Diabetes, a renowned American journal: http://diabetes.diabetesjournals.org/content/early/2016/10/25/db16-0530

Contact

Professor Jørgen Wojtaszewski
Department of Nutrition, Exercise and Sports, University of Copenhagen
Mail: jwojtaszewski@nexs.ku.dk, Telephone: +45 2875 1625

Postdoc. Rasmus Kjøbsted
Department of Nutrition, Exercise and Sports, University of Copenhagen
Mail: rasmus.kjobsted@nexs.ku.dk, Telephone: +45 2834 4370

Communications Officer Kristian Levring Madsen
Department of Nutrition, Exercise and Sports, University of Copenhagen
Mail: kma@nexs.ku.dk, Telephone: +45 4048 1684

Faculty of Science - University of Copenhagen

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.